Tajon El-Cid O MD Fort Worth, TX - 76104

Tajon El-Cid O MD is categorized under Internal Medicine Practitioners in Fort Worth, TX and active since 2012.

Tajon El-Cid O MD was established in 2012, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Internal Medicine Practitioners business, which does work in the B2C market, and is classified as a Internal Medicine Practitioners, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact El-Cid Tajon at the company’s single location by writing to 1301 Pennsylvania Avenue, Fort Worth, Texas TX 76104 or by phoning (817) 882-2000. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Tajon El-Cid O MD
Contact Person: El-Cid Tajon
Address: 1301 Pennsylvania Avenue, Fort Worth, Texas 76104
Phone Number: (817) 882-2000
Website Address: texashealth.org
Annual Revenue (USD): $500.000 to $999.999
Founded: 2012
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Internal Medicine Practitioners
SIC Code: 8011
NAICS Code: 6211110
Share This Business:

Tajon El-Cid O MD was started in 2012 to provide professional Internal Medicine Practitioners under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.

Feel free to contact El-Cid Tajon for inquiries that concern Tajon El-Cid O MD by calling the company number (817) 882-2000, as your correspondence is most welcome. Additionally, the physical location of the single location of Tajon El-Cid O MD can be found at the coordinates 32.73842,-97.34035 as well as the street address 1301 Pennsylvania Avenue in Fort Worth, Texas 76104.

For its online presence, you may visit Tajon El-Cid O MD’s website at texashealth.org and engage with its social media outlets through on Twitter and on Facebook.